No Data
No Data
Yili Chuanning Biotechnology Gets Nod to Market Ursodeoxycholic Acid
Yili Chuanning Biotechnology (SHE:301301) obtained approval from China's National Medical Products Administration for the listing of raw drug material ursodeoxycholic acid for marketing, according
Chuanning Biology (301301.SZ): Synthetic biology products such as red Sandalwood alcohol, Squalene, 5-Hydroxytryptophan, Inositol have entered the production stage.
On July 8th, Gelon Hui reported that Chuanning Biology (301301.SZ) has announced on the investor platform that its synthetic biology products, including resveratrol, squalene, 5-hydroxytryptophan, and inositol, have now entered the production phase.
Yili Chuanning Biotechnology: 2024 Interim Performance Forecast
Express News | Yili Chuanning Biotechnology Sees H1 Net Profit Ranging 730 Mln-770 Mln Yuan, up 86.8%-97% Y/Y
Chuanning Biotech (301301.SZ) is expected to increase net income by 86.76%-97.00% in the first half of the year.
On July 7th, Gelonhui announced that Chuanning Biology (301301.SZ) is expected to have a net income of 730-770 million yuan attributable to shareholders of listed companies from January 1, 2024 to June 30, 2024, an increase of 86.76%-97.00% compared to the same period last year. After deducting non-recurring gains and losses, the net profit is expected to be 730-770 million yuan, an increase of 85.95%-96.14% year-on-year. The main reasons for the growth of performance in this reporting period are: 1. due to increased market demand, the company's main products have risen in both volume and price, and revenue has increased year-on-year.
Chuanning Biological (301301.SZ): Currently, there are no plans to research weight-loss drugs.
On June 26th, Gelonhui reported that an investor asked Chunning Biotech (301301.SZ) on the interactive platform whether the company had plans to research weight loss drugs using synthetic biology. The company replied that it currently has no plans to research weight loss drugs. In the field of synthetic biology, the company focuses on health product materials, biopesticides, high value-added natural products, and high-end cosmetic raw materials sectors. It has already launched products such as red yeast alcohol and 5-hydroxytryptophan.
No Data